Patrys Limited (ASX:PAB)
0.0220
-0.0005 (-2.22%)
Nov 20, 2026, 10:40 AM AEDT
Patrys Market Cap
Patrys has a market cap or net worth of 12.81 million as of November 19, 2026. It is the 42,020th most valuable company in the world and the 1,200th biggest in Australia. Its market cap has increased by 1.60% in one year.
Market Cap
12.81M
Enterprise Value
9.45M
Revenue
8.99K
Global Rank
Country Rank
#1,200 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 12.81M, a decrease of -86.80%. That is a compound annual growth rate of -9.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 13.10M | 37.31% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Miro Sciences | 16.76M |
| Ceryvyn Therapeutics | 16.42M |
| Proteomics International Laboratories | 15.55M |
| Imugene | 15.18M |
| ReNerve | 13.96M |
| EZZ Life Science Holdings | 13.65M |
| Radiopharm Theranostics | 13.01M |
| Argenica Therapeutics | 12.85M |